Affiliation:
1. Department of Chemistry Korea University 145 Anam-ro, Seongbuk-gu Seol 02841 Republic of Korea
Abstract
AbstractA novel synthetic route to 3‐amino‐5‐halo‐2‐iodobenzoates, which are used as versatile starting materials in the synthesis of pharmaceuticals, was developed using commercially available 2‐aminobenzoates bearing a suitable halogen atom at the C5 position as the starting material. Synthesis was initiated with the introduction of a nitro group at the C3 position of the appropriate 2‐aminobenzoates, forming 2‐amino‐3‐nitrobenzoates with a C5‐halogen atom. The subsequent conversion of the C2‐amino group to an iodide yielded 5‐halo‐2‐iodo‐3‐nitrobenzoates, which were further converted into the desired 3‐amino‐5‐halo‐2‐iodobenzoates by reducing the C3‐nitro group to an amino group. It is worth noting that this transformation can be conducted on a 50 mmol scale, and the desired benzoate compounds were obtained in good yield, demonstrating the practical applicability of this protocol.
Reference39 articles.
1. Analysis of Benzenoid Substitution Patterns in Small Molecule Active Pharmaceutical Ingredients
2. As of January 20 2024 a SciFindernsubstance search was performed using benzene derivatives with substituents other than hydrogen at the 1 2 3 5-positions. This search unveiled the total number of 1 2 3 5-tetrasubstituted benzene derivatives. Subsequently a re-analysis of commercial availability and literature synthetic routes was conducted employing filter functions in Scifindern.
3. For selected examples bearing a 3-amino-5-fluorobenzoic acid moiety see:
4. The Development of Rucaparib/Rubraca®: A Story of the Synergy Between Science and Serendipity
5. Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent